
Image via PRN — Economy & Policy
Novo Nordisk: Product Launch
Novo Nordisk's investigational zenagamtide (once-weekly GLP-1 receptor agonist) demonstrated significant A1C reductions and up to 14.6% weight loss in Phase 2 study of adults with type 2 diabetes, presented at ADA 2026
Source: PRN — Economy & Policy
The leadership read
Market expansion planning requires: commercial strategy leaders, market access specialists, sales operations managers, medical science liaisons, regional commercial directors, reimbursement specialists, patient engagement leaders
Market context: the MitchelLake Talent Market Index reads 108.5 — Hot (+10.8 vs prior month); EMEA signal share is steady (-1.2pts).
MitchelLake in this thematic
Our work · 2026
Commercial Lead - March 2026
Livework Studio Ltd
EMEA · Professional Services · sales · service design
Our work · 2024
Sales Leader
Applied AI Lab
EMEA · AI, Data & Enterprise Software · ai · sales
Our work · 2024
Sales Director APAC
commercetools GmbH
EMEA · AI, Data & Enterprise Software · ecommerce · sales